REGN
Regeneron Pharmaceuticals Inc.
$557.73
-$6.90(-1.22%)
56
Overall
80
Value
45
Tech
44
Quality
Market Cap
$62.74B
Volume
1.40M
52W Range
$476.49 - $1,024.36
Target Price
$729.85
Key Metrics Overview
| Market Cap | $62.74B | P/E Ratio | 17.24 |
| 52W High | $1,024.36 | 52W Low | $476.49 |
| Div Yield | 352.0% | Payout Ratio | 18.3% |
| EPS Growth 3Y | -18.8% | 52W Position | 14.8% |
| Overall Score | 56 | Value Score | 80 |
| Quality Score | 44 | Technical Score | 45 |
Growth Analysis
| EPS Current Est | $32.36 | EPS Next Est | $31.57 |
| EPS Growth Est | -2.4% | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | REGN | $557.73 | -1.2% | 1.40M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Regeneron Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW